Target intelligence / Profile preview

Non-POU domain-containing octamer-binding protein (NONO (also commonly known as p54nrb))

Target
NONO (also commonly known as p54nrb)
Molecular classification
Transcription factor, RNA-binding protein, DNA-binding protein, Drosophila behaviour/human splicing (DBHS) family
01

Overview

Non-POU domain-containing octamer-binding protein (NONO, also known as p54nrb) is a multifunctional nuclear protein and member of the Drosophila behaviour/human splicing (DBHS) family. It binds both DNA and RNA, mediating diverse nuclear functions including pre-mRNA splicing, transcriptional regulation, DNA unwinding, and participation in nonhomologous end joining (NHEJ) for DNA repair. NONO forms functional dimers, commonly with SFPQ or PSPC1, and contributes to the assembly of paraspeckles—nuclear substructures involved in the retention of defective RNAs. Aberrant expression of NONO is implicated in a range of human diseases, especially in oncogenesis where it promotes tumor growth, metastasis, and impacts key signaling pathways such as Akt/MAPK and β-catenin. While NONO is investigated as a cancer biomarker and potential therapeutic target, the lack of selective drugs and its critical roles in normal cell biology present substantial safety and specificity challenges for therapeutic modulation.

Other names
NMT55NRB54Nuclear RNA-binding protein, 54-kDP54P54NRBPPP1R114protein phosphatase 1 regulatory subunit 114non-Pou domain-containing octamer (ATGCAAAT) binding proteinp54nrbNONO_HUMAN
02

Mechanism of action

Experimental silencing (e.g., CRISPR/Cas9) of NONO leads to inhibition of tumorigenic properties in cancer cells, including cell growth, migration, invasion, and stemness (by modulating Akt/MAPK/β-catenin pathways); no currently approved small-molecule or biologic modulators

03

Biological functions

Pre-mRNA splicingTranscriptional regulationDNA repair (nonhomologous end joining)RNA retentionRegulation of circadian rhythmDNA unwindingGene expression regulation
04

Disease associations

Cancer (especially breast cancer, bladder cancer, ovarian cancer)Neurological disease (circadian rhythm, neurodevelopmental functions)Other (involvement suggested in a variety of additional diseases through nuclear gene regulation and RNA metabolism)
05

Safety considerations

As NONO is ubiquitously expressed and involved in multiple essential nuclear processes, targeting it may present risks of broad toxicity, including impacts on RNA processing, gene expression, and cell survival in normal tissues
06

Interacting drugs

None described in the primary literature as approved drugs

1 more in the full profile.

07

Biomarkers

NONO overexpression as a potential cancer biomarker (e.g., breast cancer, bladder cancer)correlated with tumor progression and metastasis

Beyond the preview

Go deeper on Non-POU domain-containing octamer-binding protein (NONO (also commonly known as p54nrb)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-POU domain-containing octamer-binding protein (NONO (also commonly known as p54nrb)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call